Internal Medicine, Rheumatology · Portland, OR
NPI
1609074723
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3550 N Interstate Ave
Portland, OR, 97227
Phone (800) 813-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,416
48 services
Medicare patients, 2024
13
Average age 61
Drug cost, 2024
$2.8M
3,285 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Brian L Greenberg prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 766 prescriptions and refills. In total Brian L Greenberg wrote 3,285 Medicare prescriptions that cost $2.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 766 | 2,024 | 241 | $18K |
| Prednisone Generic | 594 | 1,347 | 219 | $6,983 |
| Hydroxychloroquine Sulfate Generic | 255 | 740 | 93 | $9,037 |
| Leflunomide Generic | 204 | 592 | 76 | $6,307 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 199 | 258 | 38 | $291K |
| Allopurinol Generic | 138 | 378 | 33 | $1,785 |
| Enbrel Sureclick Etanercept | 133 | 133 | 15 | $649K |
| Sulfasalazine Generic | 111 | 321 | 39 | $5,758 |
| Xeljanz Tofacitinib Citrate | 102 | 104 | 17 | $264K |
| Sulfasalazine Dr Sulfasalazine | 65 | 173 | 23 | $2,932 |
| Actemra Actpen Tocilizumab | 63 | 63 | Under 11 | $137K |
| Rasuvo Methotrexate/Pf | 58 | 78 | 18 | $32K |
| Colchicine Generic | 58 | 134 | 25 | $1,786 |
| Orencia Clickject Abatacept | 49 | 49 | Under 11 | $225K |
| Tyenne Autoinjector Tocilizumab-Aazg | 47 | 47 | Under 11 | $82K |
Brand drugs: 1,134 claims; generic drugs: 2,151 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Brian L Greenberg were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.